![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2006 Chen et al.; licensee BioMed Central Ltd. Identification of ciliary and ciliopathy genes in Caenorhabditis elegans through comparative genomics 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA 2Department of Molecular Biology and Biochemistry, Simon Fraser University, University Drive, Burnaby, British Columbia, Canada V5A 1S6 3School of Biomolecular and Biomedical Sciences, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland 4Department of Zoology, University of British Columbia, West Mall, Vancouver, British Columbia, Canada V6T 1Z4 5Karolinska Institute, Department of Biosciences and Nutrition, Södertörn University College, School of Life Sciences, S-14189 Huddinge, Sweden 6British Columbia Cancer Agency, Genome Sciences Centre, Vancouver, British Columbia, Canada V5Z 4S6 Corresponding author.Nansheng Chen: chenn/at/sfu.ca; Allan Mah: amaha/at/sfu.ca; Oliver E Blacque: oblacqua/at/sfu.ca; Jeffrey Chu: jeff.sc.chu/at/gmail.com; Kiran Phgora: kiran_phgora/at/sfu.ca; Mathieu W Bakhoum: bakhoum/at/sfu.ca; C Rebecca Hunt Newbury: crebecca/at/interchange.ubc.ca; Jaswinder Khattra: jkhattra/at/bcgsc.ca; Susanna Chan: schan/at/bcgsc.ca; Anne Go: ago/at/bcgsc.ca; Evgeni Efimenko: evgeni.efimenko/at/biosci.ki.se; Robert Johnsen: bjohnsen/at/gene.mbb.sfu.ca; Prasad Phirke: prasad.phirke/at/biosci.ki.se; Peter Swoboda: peter.swoboda/at/sh.se; Marco Marra: mmarra/at/bcgsc.ca; Donald G Moerman: moerman/at/zoology.ubc.ca; Michel R Leroux: leroux/at/sfu.ca; David L Baillie: baillie/at/sfu.ca; Lincoln D Stein: lstein/at/cshl.edu Received August 8, 2006; Revised October 20, 2006; Accepted December 22, 2006. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Background The recent availability of genome sequences of multiple related Caenorhabditis species has made it possible to identify, using comparative genomics, similarly transcribed genes in Caenorhabditis elegans and its sister species. Taking this approach, we have identified numerous novel ciliary genes in C. elegans, some of which may be orthologs of unidentified human ciliopathy genes. Results By screening for genes possessing canonical X-box sequences in promoters of three Caenorhabditis species, namely C. elegans, C. briggsae and C. remanei, we identified 93 genes (including known X-box regulated genes) that encode putative components of ciliated neurons in C. elegans and are subject to the same regulatory control. For many of these genes, restricted anatomical expression in ciliated cells was confirmed, and control of transcription by the ciliogenic DAF-19 RFX transcription factor was demonstrated by comparative transcriptional profiling of different tissue types and of daf-19(+) and daf-19(-) animals. Finally, we demonstrate that the dye-filling defect of dyf-5(mn400) animals, which is indicative of compromised exposure of cilia to the environment, is caused by a nonsense mutation in the serine/threonine protein kinase gene M04C9.5. Conclusion Our comparative genomics-based predictions may be useful for identifying genes involved in human ciliopathies, including Bardet-Biedl Syndrome (BBS), since the C. elegans orthologs of known human BBS genes contain X-box motifs and are required for normal dye filling in C. elegans ciliated neurons. Background The cilium is an evolutionarily conserved subcellular organelle that projects from the surface of many eukaryotic cells in vertebrates, including kidney and endothelial cells, myocardial cells, odontoblasts, retinal photoreceptor cells and cortical and hypothalamic neurons [1]. The biogenesis and maintenance of cilia is dependent on intraflagellar transport (IFT), which is a bidirectional motility process driven by anterograde and retrograde motors that operate along the microtubule-based ciliary axoneme [2]. Consistent with the ubiquitous distribution of cilia, many physiological processes are critically dependent on their function, which can be broadly classified into two categories, namely cell (and fluid) motility and sensory perception [3]. Defects in the molecular components of cilia and IFT are associated with a variety of human disorders, including cystic kidney disease, primary cilia dyskinesia, retinitis pigmentosa, and Bardet-Biedl syndrome (BBS) [1,3-5]. Because of the importance of cilia function in diverse physiological processes and pathological conditions, significant efforts have recently been made to identify the molecular components of these organelles (reviewed by Inglis et al. [5]). A key finding, which has provided the groundwork for uncovering new ciliary genes, was the discovery in 2000 by Swoboda et al. [6] that C. elegans transcription factor DAF-19 regulates the expression of key ciliogenic genes (for example, che-2, osm-1, and osm-6), and is, therefore, required for building and maintaining nematode ciliary structures. DAF-19 is orthologous to human RFX transcription factors, which bind to cis-regulatory elements called X-box motifs [7]. The identification of DAF-19 and its cognate binding motifs has greatly facilitated the identification of many novel ciliary genes both in C. elegans (for example, bbs-3/arl-6 [8], bbs-5 [9] and bbs-8 [10]), and in the fruit fly Drosophila melanogaster [11]. Interestingly, all but 3 of the 11 known human BBS genes (BBS6 [12], BBS10 [13,14] and BBS11 [15]) have clear one-to-one C. elegans orthologs. All studied C. elegans bbs genes have readily identifiable X-box motifs in their promoters and all are exclusively expressed in ciliated neurons [8-10]. In addition, loss-of-function C. elegans bbs alleles possess ciliary structure abnormalities, including an inability to take up fluorescent dyes [16-20]. Similar to bbs gene mutants, dye-filling defect (Dyf) phenotypes are found in other ciliary and IFT mutants, including dyf-1 through dyf-13, as well as many Osm (osmotic avoidance abnormal) and Che (abnormal chemotaxis) mutants [3]. Taken together, the above findings underscore the importance of the daf-19/X-box system in regulating C. elegans cilia formation and demonstrate that C. elegans is a very useful model for identifying new human BBS genes. The discovery of the DAF-19/X-box regulatory system also provided the rationale for using bioinformatics and genomics approaches to screen for additional C. elegans genes required for cilia function using bioinformatics and genomics approaches [5]. In one such project, Efimenko et al. [16] screened C. elegans promoters for X-box motifs that match an 'average' X-box consensus, producing a set of 758 putative X-box-regulated genes with one or more X-boxes within 1,000 base-pairs (bp) upstream of the start codon. Similarly, Blacque et al. [17] scanned the C. elegans genome for candidate X-boxes that match a hidden Markov model (HMM) [21] profile assembled from known X-box motif sequences, revealing a set of 1,572 genes with putative X-boxes within 1,500 bp upstream of the start codon. Applying a more stringent criterion of X-boxes within 250 bp upstream of the start codon, 293 genes were uncovered. Blacque et al. also performed serial analysis of gene expression (SAGE) on ciliated and non-ciliated cell types in C. elegans and searched for genes with a 1.5-fold or greater level of expression in the ciliated subset of neuronal cells versus predominantly non-ciliated cell subsets (that is, pan-neuronal, intestinal and muscle cell subsets). Combining the X-box and SAGE data, Blacque et al. [17] were able to further refine their list of candidate ciliary genes from 293 genes to a final total of 46 genes. Although the above studies [16,17] produced large gene sets that contain many known and putative X-box regulated genes, including protein kinases, receptors, and transcription factors [5,16,17], both approaches are limited by high false positive rates. In addition, both may have high false negative rates, especially with more stringent candidate gene sets such as the X-box-containing genes where X-boxes are considered only within 250 bp upstream of the start codon. Since candidate X-box motifs fall outside of the 250 bp (from the start codon) range, many genes may potentially be omitted. For example, a candidate X-box motif in the promoter of arl-6 (bbs-3) is >1,000 bp upstream of the start codon and was missed by both projects but uncovered when the search space was extended to 1,500 [8] (Table 1).
Other approaches used to identify new ciliary genes include microarray expression profiling of isolated chemosensory neurons [22] and labeled ciliated neurons [23]. These C. elegans-based approaches uncovered ciliated-neuron specific genes, including X-box regulated genes and non-X-box regulated genes. Although such gene profiling approaches have been successful in identifying candidate ciliary genes, in particular those that are not directly regulated by X-box motifs, they are less effective in identifying X-box regulated genes since not all ciliary genes are X-box regulated. Nevertheless, results from these functional genomics studies can be combined with data from comparative genomics analyses for prediction and data validation (see also [9,11]). Although many ciliary genes have been identified, it is certain that many more remain undiscovered, including new BBS and IFT components. Indeed, underscoring this notion is the fact that all of the studied BBS proteins [8,18], as well as several novel ciliary genes that encode IFT proteins with roles in building C. elegans cilia, including dyf-1 [19], dyf-2 [24], dyf-3 [25], dyf-6 [26], dyf-13 [17] and ifta-1 [27], have only very recently been identified and characterized. It is also interesting to note that not all BBS patient cohorts are accounted for by mutations in known BBS genes [28,29], indicating that additional BBS genes likely remain to be identified in C. elegans. For these reasons, the aim of this project is to identify additional ciliary genes, including potential BBS gene candidates. To do this, we have taken a comparative genomics approach, based on the rationale that ciliary genes from related nematode species are similarly dependent on X-box motifs for their transcriptional regulation. The sequence availability of several C. elegans sister species has now made such a comparative approach possible. Specifically, the C. briggsae genome has been sequenced and annotated [30], as has the C. remanei genome. With comparative genomics, the distance-to-start codon requirement can be relaxed (to 2,000 bp upstream of the start codon) so that more genuine X-boxes can be retained. Additionally, comparative genomics avoids the data noise and biased sampling associated with functional genomics (including microarray expression profiling and SAGE). Using this strategy, we have identified 93 known and putative ciliary genes, including some that are known to be, or likely to be associated with cilia biogenesis and human ciliary disorders. In addition, our comparative genomics approach was used to clone a novel X-box-containing gene, dyf-5, which when mutated results in abnormal dye filling of ciliated neurons. Results Identification of ciliary genes using comparative genomics To identify X-box motif-regulated C. elegans genes, we performed a genome-wide screen for the X-box motif using the HMMER program [21] and a HMM profile generated from a set (15 motifs from 13 genes; Additional data file 1) of experimentally validated instances of X-box motifs in C. elegans. Using this approach, we uncovered 4,291 individual X-box motifs (Figure (Figure1),1
Anatomical expression analysis To assess the validity of our procedure in identifying bona fide X-box containing genes, which we would expect to be expressed only in C. elegans ciliated neurons, we examined available C. elegans anatomical gene expression pattern data in WormBase [31,32], the published literature, and the British Columbia promoter::GFP transgenic strains database [33] (Table 1). Among the 93 candidate X-box-containing genes that we have identified (Additional data file 2), 25 had pre-engineered promoter::GFP transgenic strains and recorded expression profiles. Of these 25 genes, 24 were found to be expressed in the ciliated amphid (head) and/or phasmid (tail) neurons (Table 1), as expected for genes required for cilia function or ciliated cell differentiation; 4 of the 24 genes showed additional weak signals in the gut and other tissues (for example, pharyngeal signals for C04C3.3) (Table 1). One gene was not expressed in ciliated neurons but instead showed expression in the pharynx (Y37D8A.17). Hence, we estimate the false positive prediction rate to be also very low, at approximately 4% (1/25). As described in Table 1, 7 of the 25 genes are as yet uncharacterized. Except for C04C3.3, these genes are exclusively expressed in ciliated neurons (five genes are shown in Figure Figure2),2
SAGE data analysis It is anticipated that the transcriptional expression pattern of X-box regulated genes will be strongly correlated with that of daf-19, which encodes the transcription factor that binds to the X-box motif [6]. To address this hypothesis, we employed a series of SAGE datasets that were previously generated by the C. elegans Gene Expression Consortium [33] for various tissue types, including the ciliated cell subset of neuronal cells [17]. For each type of tissue analyzed by SAGE, we determined the number of expressed tags corresponding to daf-19 and to each of the 93 candidate X-box genes (Additional data file 2). We then calculated Pearson correlation coefficient (PCC) values between the daf-19 and X-box gene tag counts using a procedure described previously [34]. Among the 93 candidate genes, 50 possessed usable SAGE tags that could be unambiguously mapped to a single gene model and had at least five tags in one or more tissue libraries (Table 1, Additional data file 2) [35]. As illustrated in Figure Figure3,3
Microarray analysis for DAF-19 regulated genes To further ascertain whether the X-box-containing genes identified in Additional data file 2 are regulated by the DAF-19 ciliogenic transcription factor, we carried out microarray analysis using Affymetrix chips that encompass >95% of all C. elegans genes and compared the expression profiles of daf-19(+) and daf-19(-) animals. The entire dataset, obtained from two separate microarray experiments, lists the expression data for 15,879 genes (Additional data file 3), and is ordered by genes with the highest level of down regulation in daf-19(-) animals compared to the daf-19(+) control animals. Among these genes, 466 genes show a down regulation of 2.0-fold or higher. To estimate the sensitivity of this approach, we examined the enrichment of genes used for generating the X-box HMM profile (shown in Additional data file 1) and found that 9/13 (69%) are highly enriched in the daf-19(+) animals (that is, down regulated in the absence of DAF-19), which indicates 69% sensitivity. Similarly, to estimate the specificity of this approach, we examined the top 50 genes in the entire dataset (shown in Additional data file 3) and found that 29 (58%) genes are well characterized X-box regulated genes (for example, osm-6, xbx-1, dyf-1, dyf-2, che-2, che-3 and bbs-5), contain conserved X-box motifs in all three species (for example, ZK418.3 and T28F3.6) or are exclusively expressed in ciliated neurons (for example, C33A12.4 [23], K07G5.3 [17] and F53A9.4 [23]). These data suggest that the microarray approach shows a better level of specificity and sensitivity than the SAGE approach, which was found to have a 67% false-positive rate [17]. Among the 83 X-box-containing genes in Additional data file 2 that have human homologs, 61 genes have usable microarray results; 25 of these are enriched more than 2-fold in the daf-19(+) strains (Additional data file 2), suggesting that these X-box-containing C. elegans genes contain significantly (p = 7.6 × e-9, Fisher's exact test) overrepresented genes that are dependent on DAF-19 for expression compared to the genome-wide data. Approximately half of all X-box containing genes that show both strong correlation in gene expression with daf-19 (PCC = 0.4) and whose expression requires daf-19 (ratio = 2.0) are well known cilium-specific genes, including bbs-2, bbs-5, bbs-8, che-2 and osm-5 (Table 2). The other genes in Table 2 represent strong candidates for ciliary genes.
Identification of the dyf-5 gene Since all studied C. elegans orthologs of known human BBS genes and other ciliogenic genes (for example, IFT genes) possess a dye-filling defect when disrupted, we were interested in determining whether any of the 93 genes in the candidate X-box gene dataset (Additional data file 2) correspond to previously described C. elegans dyf alleles that have not been cloned. To do this, we obtained the predicted genetic map locations for each of the candidate X-box genes and investigated whether they overlapped with the genetic intervals of uncloned dyf alleles [36] in the C. elegans genome. This analysis revealed three strong matches: dyf-2/ZK520.3, dyf-5/M04C9.5 and dyf-10/C48B6.8. One of these genes, dyf-2, was independently identified during the course of this project and was found to encode an IFT protein in another study [24]. The uncloned gene dyf-10(e1383), maps to chromosome I:1.56 +/- 0.043 cM [36]. Since the C48B6.8 (gk471) deletion mutant we obtained from the C. elegans knockout consortium is dye-filling defective (data not shown) and maps within the genetic interval of dyf-10(e1383), we tested the hypothesis that the two genes were the same. We sequenced the coding regions and intron-exon boundaries of C48B6.8 from the dyf-10 strain but found no mutations. Given the possibility of lesions in non-coding region(s) such as the promoter, we performed complementation analyses. C48B6.8 (gk471) mutant males were crossed to dyf-10(e1383) hermaphrodites, and the resulting progeny took up dye. Thus, the two mutations are likely to be in different genes, and dyf-10 remains uncloned. However, the finding that the C48B6.8 mutant exhibits a Dyf phenotype is consistent with the fact that it is the homolog of the recently identified BBS9 gene [28], as all bbs mutants tested to date have ciliary abnormalities and are Dyf [18,20]. In contrast to our efforts to clone dyf-10, we were successful in identifying the dyf-5(mn400) mutation, which was mapped by Wicks et al. [37]. Specifically, we found that dyf-5(mn400) animals carry a G→A point mutation in the second coding exon of M04C9.5, which creates a premature stop codon (TAG) in the predicted serine/threonine kinase domain of this gene (Figure (Figure4).4
Discussion The aim of this project was to identify novel ciliary/ciliopathy genes by using a comparative genomics approach that exploits emerging sequence and sequence annotation data of related animal species. Here, we have identified an extensive list (total 93) of candidate X-box regulated genes, of which approximately one-third are known X-box-regulated/ciliary genes. Many, or even the majority, of these candidate ciliary genes when mutated may cause a dye filling defect. Since the majority (83 out of 93) of the candidate X-box-regulated genes in C. elegans have readily identifiable human orthologs (Additional data file 2), it would be productive to screen patients with known ciliopathies, such as BBS, for mutations affecting some of these genes. In addition, based on the correlation between the Dyf phenotype and ciliary gene function, the regulation of such genes by the X-box-binding DAF-19 transcription factor, and the conservation of such motifs across sister Caenorhabditis genomes, we have successfully cloned dyf-5 and identified at least one other dyf gene, namely ZK520.3 for dyf-2, which has been characterized elsewhere [24]. The cloning of these dyf genes has demonstrated the effectiveness of the combined comparative genomics and genetics analysis approach presented here. The newly cloned dyf-5 gene may be a C. elegans ortholog of a yet unidentified human BBS or other ciliopathy-associated gene since all studied C. elegans orthologs of known human BBS genes result in a Dyf phenotype when disrupted [18,20,40]. Because transcriptional regulatory motifs are generally short (less than 20 bp) and degenerate, many thousands of potential binding sites for any given transcription factor are expected to be found by chance [41] and this poses a great challenge in identifying bona fide binding sites, especially in large eukaryote genomes. Our approach overcomes such a challenge by using comparative genomics and the recent availability of multiple sister Caenorhabditis genomes. In the context of identifying transcription factor binding sites and target genes, such an approach is arguably advantageous compared to approaches that rely on co-expression, which can be coincidental or even secondary to a common transcriptional regulatory pathway and thus lead to a high rate of false positives. Indeed, many of the 466 daf-19 regulated genes identified in this study by microarray expression profiling do not contain the X-box motif in their promoters and are not necessarily directly regulated by DAF-19. Furthermore, comparative genomics is advantageous because it does not encounter problems of data noise and biased sampling associated with functional genomics projects. On the other hand, the comparative genomics based strategy reveals only highly conserved motifs while others are regarded as false positives and discarded accordingly. One caveat of this rather conservative filtering procedure is that species-specific binding motifs, or more divergent motifs, are mistakenly discarded, leading to a non-negligible false negative rate. Therefore, the candidate X-box regulated genes identified in this project may only represent a portion of the entire set of bona fide X-box regulated genes in C. elegans. In fact, there are still seven dyf genes (dyf-4, dyf-7, dyf-8, dyf-9, dyf-10, dyf-11 and dyf-12) in C. elegans that remain to be identified. However, we should be aware that not all of the uncloned dyf genes are DAF-19 and X-box dependent (for example, genes such as daf-6 [42] that are expressed in the sheath cell or socket cell when mutated can also lead to the Dyf phenotype). To clone these bona fide X-box-regulated dyf genes and identify additional X-box regulated genes, some of which might be uncloned osm or che genes, we will need to have a more detailed understanding of the properties of X-box motifs, including the variation, preferred position in the promoter, and interaction with other binding motifs. Some of these questions will be at least partially addressed after we have validated more of our candidate X-box-containing genes in C. elegans. This study and previous studies [6,10,16,17] have found that the majority of known X-boxes are located within 250 bp upstream of the translational start site (ATG). However, many genuine X-boxes reside far outside of this optimal region, further suggesting that other factors or properties of X-boxes that are critical for their functions remain to be identified. Additionally, improvement in gene curation and the emergence of more related sequenced genomes, including Caenorhabditis japonica and CB5161, will undoubtedly serve to reduce false negative hits and reveal more targets. Lastly, functional genomics approaches, including ChIP-Chip [43], SACO [44], or ChIP-PET [45,46] technologies, will help to identify more novel candidate genes, in particular species-specific ones. Conclusion Our study demonstrates how comparative genomics is a powerful tool for facilitating identification of novel genes and positional cloning. In this study, we exploited the prior understanding of known BBS genes, the C. elegans dye filling defect phenotype, and, most importantly, the presence of a shared synteny of regulatory (X-box) motifs among conserved genes. It will be of great interest to pursue the characterization of the many X-box containing genes identified in this study, in particular with respect to their possible involvement in ciliary function and as candidates for BBS/ciliopathy-associated genes. Materials and methods Data mining and gene finding Genomic sequences and gene annotations of C. elegans and C. briggsae were obtained from WormBase stable release WS150 [32]. Genomic sequences of C. remanei were obtained from the ftp site of the development site of WormBase. Since the C. remanei genome sequencing project is still in progress, a consensus gene set is not yet available. To annotate the PCAP-assembled [47]C. remanei genome, a homology-based gene finding program Exonerate (version 1.0.0) [48] was used. All sequence and annotation data were dumped into and retrieved from a MySQL database using the Bio::DB::GFF schema [49], and were viewed using the Generic Genome Browser [49]. HMMER and motif finding The HMMER program package was downloaded from Sean Eddy's website [21,50]. Release version HMMER 1.8.5 was used because it has been tested and extensively used for DNA sequence analysis. Fifteen X-box motifs (from thirteen genes, shown in Additional data file 1) were aligned using the program ClustalW [51] before being fed to the hmmb and hmmfs programs for creating an HMM profile and searching instances of X-box motifs, respectively. Results were parsed and loaded into the Bio::DB::GFF database for further analysis. SAGE analysis SAGE libraries were downloaded from the British Columbia C. elegans Gene Expression Consortium, Canada [33,34]. Before being used for gene expression analysis, SAGE tags were filtered for usable tags. Each of these usable tags can be unambiguously mapped to a single gene model and its tag frequency has to be five or more in at least one of the SAGE libraries. The density curves for PCC values were generated using the statistics package R [52] as reported previously [34]. Promoter::GFP transgenic strains The engineering procedure was as described in our previous publications [53,54]. Briefly, the GFP coding sequence was 'stitched' together with the promoter of the gene of interest following the procedure developed by Oliver Hobert [55], followed by injection of the constructs into dpy-5 worms [56]. A wild-type dpy-5 gene was co-injected. F2 dyp-5(+) worms were subsequently selected, and then placed under the microscope for analysis of GFP signals. Transgenic rescue A rescuing construct for M04C9.5 was generated by PCR amplifying a 3,773 bp fragment of N2 genomic DNA encompassing the M04C9.5 gene and flanking sequences using the primers: M04C9.5F2 5' GAAAAAAAAGTATTTGTAACG3' and M04C9.5R2 5' GGATATTTCAGCACCATGAG 3'. Microinjection was performed as described [57]. Briefly, 50 ng/μl of rescuing construct along with 100 ng/μl of pCeh361 (a dpy-5 rescuing plasmid [56]) and 20 ng/μl of pmyo-2::GFP (dominant marker, gift from A Fire in Stanford University) was co-injected into dpy-5(e907) worms. The M04C9.5 rescuing constructs were crossed into the dyf-5(mn400) mutant background and assayed for rescue of the dye-filling defective phenotype by DiI staining [36]. Gene sequencing The same PCR fragments used for transgenic rescue were used for sequencing of the M04C9.5 genomic regions. The constructs were subsequently PCR purified and sent to Macrogen [58] for sequencing. Sequencing primers are included in Additional data file 4. Complementation test DAF-19 microarray expression profiling Embryo preparation daf-19(-) animals (daf-19(m86);daf-12(sa204)) and daf-19(+) animals (daf-12(sa204)) were grown to adult stage on solid media. Note that the daf-12(sa204) mutation suppresses the Daf-c phenotype of daf-19(m86), thereby allowing us to obtain large populations of daf-19(-) worms. Eggs were prepared from gravid adults using a hypochlorite treatment [59], resuspended in 10 mM Tris-EDTA (pH 7.5) and stored at -80°C. RNA isolation, analysis and labeling Thawed embryos were disrupted using syringes fit with a 26-gauge needle. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, California, USA) coupled with phase lock gel tubes (Eppendorf, Hamburg, Germany). Extracted RNA was subjected to rigorous quality assessment and quantification using the RNA Nano LabChip Kit (Agilent Technologies, Santa Clara) with the 2100 Bioanalyzer (Agilent Technologies). Numerical measures of RNA quality (rRNA ratio, RNA integrity number) were employed to ensure the high quality of extracted RNA. Good quality total RNA (5 micrograms) was subjected to a standard eukaryotic target preparation protocol as detailed in the GeneChip Expression Analysis Technical Manual (provided by Affymetrix, Santa Clara, California, USA) [60]. GeneChip hybridization, washing, staining, and scanning A hybridization cocktail mixture was made for each labeled RNA sample. Each cocktail included spikes of GeneChip hybridization controls, which served as measures of hybridization quality and array performance. Each sample was subsequently hybridized to an Affymetrix GeneChip C. elegans genome array. This high-density GeneChip simultaneously probes for over 22,500 C. elegans transcripts. Sixteen-hour hybridizations were performed in a GeneChip Hybridization Oven 640, followed by automated washes and staining in a GeneChip Fluidics Station 450 controlled by GeneChip operating software (GCOS). The procedure involved a single stain protocol using a streptavidin-phycoerythrin conjugate coupled with antibody amplification of fluorescent signal. Lastly, scanning and image capture were done with a solid-state green laser GeneChip Scanner 3000. Raw data processing and technical quality assessments The raw array images were visually inspected for artifacts and for proper grid-alignment. Data processing followed using GCOS software, with a chip-by-chip analysis to assess global trends in expression data. For each analysis, signal intensities were scaled to All Probe Sets with a Target Signal setting of 500, the Normalization Value was set to 1, and default settings were used for the remaining expression analysis parameters. Relative scaling factors, average background and noise values were confirmed to be within ranges considered satisfactory as per the Affymetrix Data Analysis Fundamentals manual (provided by Affymetrix) [61]. Signals from spiked hybridization controls were checked to ensure that the limits of assay sensitivity were achieved. Ratios of the 3' versus 5' probe sets for selected endogenous transcripts (beta-actin and GAPDH), ideally approaching a value of 1, were checked to ensure efficiencies in cDNA synthesis and in vitro transcription reactions. Chips meeting all these quality metrics were passed for higher level analysis. Microarray datasets used for this project have been submitted to the Gene Expression Omnibus (GEO) database [62]. The GEO accession numbers are GSE6563 (project number), GSM151745 (daf-19(m86);daf-12(sa204), GSM151746 (daf-19(m86);daf-12(sa204)), GSM151747 (daf-12(sa204)), and GSM151748 (daf-12(sa204)). Additional data files The following additional data are available with the online version of this paper. Additional data file 1 is a table listing previously identified X-box motifs in C. elegans. These motifs were used as input to generate an HMM profile for finding novel X-box motifs. Additional data file 2 is a table listing known and newly identified X-box-regulated genes in C. elegans. Additional data file 3 is a table listing Affymetrix microarray analysis results. Additional data file 4 is a list of sequencing primers for identifying dyf-5. Additional data file 1 These motifs were used as input to generate an HMM profile for finding novel X-box motifs. Click here for file(36K, doc) Additional data file 2 Known and newly identified X-box-regulated genes in C. elegans. Click here for file(178K, doc) Acknowledgements LDS is funded by NHGRI. NC is supported by grants from NHGRI, NSERC and a start-up fund from Simon Fraser University. DLB is supported by grants from NSERC, CIHR of Canada and from Genome Canada and Genome British Columbia. DGM and MAM are supported by Genome Canada and Genome British Columbia. MRL is supported by a grant from the March of Dimes and holds scholar awards from CIHR and MSFHR. OEB was supported by a MSFHR fellowship and is currently supported by Science Foundation Ireland. AM is supported by an NSERC scholarship. Work in the laboratory of PS is supported by grants from the Swedish Research Council (VR) and from the Swedish Foundation for Strategic Research (SSF). Jamie Inglis worked on this project when he was a summer student in the Stein lab. Strains containing the dyf-5(mn400), dyf-5/M04C9.5(ok1170), daf-19(m86), daf-12(sa204), dyf-10(e1383) and C48B6.8 (gk471) mutant alleles were obtained from the Caenorhabditis Genetics Center (CGC). We thank Kim Wong who participated the in the microarray analysis project and Richard Karhol and Allen Delaney for submitting the microarray data to the Gene Expression Omnibus (GEO). We thank Doreen Ware for critical review of the manuscript. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Annu Rev Genomics Hum Genet. 2006; 7():125-48.
[Annu Rev Genomics Hum Genet. 2006]Cell Motil Cytoskeleton. 1998; 39(4):347-8.
[Cell Motil Cytoskeleton. 1998]Annu Rev Cell Dev Biol. 2003; 19():423-43.
[Annu Rev Cell Dev Biol. 2003]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Mol Cell. 2000 Mar; 5(3):411-21.
[Mol Cell. 2000]Nucleic Acids Res. 1996 Mar 1; 24(5):803-7.
[Nucleic Acids Res. 1996]Nat Genet. 2004 Sep; 36(9):989-93.
[Nat Genet. 2004]Cell. 2004 May 14; 117(4):541-52.
[Cell. 2004]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Development. 2005 Apr; 132(8):1923-34.
[Development. 2005]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Nucleic Acids Res. 1999 Jan 1; 27(1):260-2.
[Nucleic Acids Res. 1999]Nat Genet. 2004 Sep; 36(9):989-93.
[Nat Genet. 2004]Curr Biol. 2004 Dec 29; 14(24):2245-51.
[Curr Biol. 2004]Genome Biol. 2005; 6(2):R17.
[Genome Biol. 2005]Cell. 2004 May 14; 117(4):541-52.
[Cell. 2004]Cell. 2004 May 14; 117(4):527-39.
[Cell. 2004]Nat Genet. 2004 Sep; 36(9):989-93.
[Nat Genet. 2004]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Mol Biol Cell. 2006 Nov; 17(11):4801-11.
[Mol Biol Cell. 2006]J Mol Biol. 2005 Feb 25; 346(3):677-87.
[J Mol Biol. 2005]Nucleic Acids Res. 1999 Jan 1; 27(1):260-2.
[Nucleic Acids Res. 1999]Development. 2005 Apr; 132(8):1923-34.
[Development. 2005]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]PLoS Biol. 2003 Nov; 1(2):E45.
[PLoS Biol. 2003]Mol Cell. 2000 Mar; 5(3):411-21.
[Mol Cell. 2000]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D383-9.
[Nucleic Acids Res. 2005]Cold Spring Harb Symp Quant Biol. 2003; 68():159-69.
[Cold Spring Harb Symp Quant Biol. 2003]Mol Cell. 2000 Mar; 5(3):411-21.
[Mol Cell. 2000]Cold Spring Harb Symp Quant Biol. 2003; 68():159-69.
[Cold Spring Harb Symp Quant Biol. 2003]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Genome Res. 2006 May; 16(5):606-17.
[Genome Res. 2006]Genome Res. 2001 Aug; 11(8):1346-52.
[Genome Res. 2001]Genome Biol. 2005; 6(2):R17.
[Genome Biol. 2005]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Mol Biol Cell. 2006 Nov; 17(11):4801-11.
[Mol Biol Cell. 2006]Am J Hum Genet. 2005 Dec; 77(6):1021-33.
[Am J Hum Genet. 2005]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Nat Genet. 2006 Mar; 38(3):363-8.
[Nat Genet. 2006]Nat Genet. 2001 Jun; 28(2):160-4.
[Nat Genet. 2001]Mol Cell Proteomics. 2002 Jun; 1(6):451-65.
[Mol Cell Proteomics. 2002]J Cell Biol. 2005 Jul 4; 170(1):103-13.
[J Cell Biol. 2005]Mol Biol Cell. 2006 Nov; 17(11):4801-11.
[Mol Biol Cell. 2006]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Nat Genet. 2006 Mar; 38(3):363-8.
[Nat Genet. 2006]Mol Cell Biol. 1990 May; 10(5):2261-8.
[Mol Cell Biol. 1990]Curr Opin Genet Dev. 2005 Aug; 15(4):395-402.
[Curr Opin Genet Dev. 2005]Dev Cell. 2005 Jun; 8(6):893-906.
[Dev Cell. 2005]Mol Cell. 2000 Mar; 5(3):411-21.
[Mol Cell. 2000]Nature. 2003 Oct 9; 425(6958):628-33.
[Nature. 2003]Development. 2005 Apr; 132(8):1923-34.
[Development. 2005]Science. 2000 Dec 22; 290(5500):2306-9.
[Science. 2000]Cell. 2004 Dec 29; 119(7):1041-54.
[Cell. 2004]Nat Methods. 2005 Feb; 2(2):105-11.
[Nat Methods. 2005]Cell. 2006 Jan 13; 124(1):207-19.
[Cell. 2006]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D383-9.
[Nucleic Acids Res. 2005]Genome Res. 2003 Sep; 13(9):2164-70.
[Genome Res. 2003]BMC Bioinformatics. 2005 Feb 15; 6():31.
[BMC Bioinformatics. 2005]Genome Res. 2002 Oct; 12(10):1599-610.
[Genome Res. 2002]Nucleic Acids Res. 1999 Jan 1; 27(1):260-2.
[Nucleic Acids Res. 1999]Methods Enzymol. 1996; 266():383-402.
[Methods Enzymol. 1996]Cold Spring Harb Symp Quant Biol. 2003; 68():159-69.
[Cold Spring Harb Symp Quant Biol. 2003]Genome Res. 2006 May; 16(5):606-17.
[Genome Res. 2006]Proc Natl Acad Sci U S A. 2005 Jan 4; 102(1):146-51.
[Proc Natl Acad Sci U S A. 2005]J Biol Chem. 2005 Nov 18; 280(46):38787-94.
[J Biol Chem. 2005]Methods Biochem Anal. 2006; 47():203-26.
[Methods Biochem Anal. 2006]Cell Mol Life Sci. 2006 May; 63(10):1193-204.
[Cell Mol Life Sci. 2006]Methods Cell Biol. 1995; 48():451-82.
[Methods Cell Biol. 1995]Cell Mol Life Sci. 2006 May; 63(10):1193-204.
[Cell Mol Life Sci. 2006]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Methods Mol Biol. 2006; 338():175-90.
[Methods Mol Biol. 2006]